CELZ Creative Medical Technology Holdings, Inc.
-
Creative Medical Technology Missed Consensus Estimates
Friday, November 6, 2026 · 12:00 AM ET
Creative Medical Technology (CELZ) reported a loss of $0.40 per share on revenue of $0.00 million for the third quarter ended September 2026. The consensus estimate was a loss of $0.24 per share. The company missed consensus estimates by 66.67%.
Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.
Reported Earnings
($0.40)
Earnings Whisper®
—
Consensus Estimate
($0.24)
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—
*Reported earnings and revenue figures shown above, and any guidance given, are preliminary and may be updated upon further review.*